Article Text
Abstract
People with Parkinson's disease have limited brain reserves of endogenous dopamine; thus, their medications must not be omitted or delayed as this may lead to a significant drop in brain dopamine levels. This has two main clinical consequences: first, a deterioration in disease control, with distressing symptoms such as tremor, pain, rigidity, dysphagia and immobility, and second, an increased risk of developing the life-threatening complication of neuroleptic malignant-like syndrome. Common reasons for people with Parkinson's disease being unable to take their oral medications are neurogenic dysphagia from progressive disease or concurrent illness, gastroenteritis, iatrogenic ‘nil by mouth’ status especially perioperatively, and impaired consciousness level. Here we outline alternative methods to give dopaminergic drugs in the acute setting to people with Parkinson's disease who cannot take their usual oral treatment, namely using dispersible preparations in thickened fluids, an enteral tube, a transdermal patch or subcutaneous injections.
- PARKINSON-S DISEASE
- DYSPHAGIA
- NEUROPHARMACOLOGY
- MOVEMENT DISORDERS
- PHARMACOLOGY
Statistics from Altmetric.com
Linked Articles
- Editors' commentary
Read the full text or download the PDF:
Other content recommended for you
- Initial management of Parkinson’s disease
- Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial
- Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcome
- Emergencies and critical issues in Parkinson’s disease
- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- Dopamine agonists: their role in the treatment of Parkinson's disease
- Pharmacological treatment of Parkinson's disease
- Restless legs syndrome: pathophysiology and modern management
- Initial drug treatment in Parkinson’s disease
- Developments in the treatment of Parkinson's disease